Patent · US Active

Heparan sulphate which binds BMP2

US10086044B2 · kind B2 · utility

0Cited by
0References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 11, 2009
Grant dateOct 2, 2018
Priority date
Expiry dateDec 30, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2501/90
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to heparan sulphate GAGs obtained by affinity chromatography using the heparin-binding domain of BMP2. The GAGs were obtained from osteoblast extracellular matrix and from a commercially available heparan sulfate (Celsus HS).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.